← Leaderboards
Scott Allen Noggle
Icahn School Of Medicine At Mount Sinai
$5,922,414
Attributed
$32,838,875
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.4M · FY2012–22$10M$7.5M$5M$2.5M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$32,838,875 · 4
By mechanism
U01$25,534,922 · 1
RF1$4,030,467 · 2
R01$3,273,486 · 1
Top collaborators
- Samuel E Gandy25 shared
- Vahram Haroutunian21 shared
- Bin Zhang21 shared
- Michelle E Ehrlich20 shared
- Eric E Schadt20 shared
- Koichi Iijima11 shared
- Jun Zhu11 shared
- Valentina Fossati4 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Vahram Haroutunian$39,970,462
- Bin Zhang$19,809,238
- Eric E Schadt$18,256,361
- Panagiotis Roussos$45,081,240
- Stephen R Salton$16,387,402
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposMolecularGenesNeuronsS DiseaseInduced Pluripotent Stem CellCell TypeBrainBrain CellCellsCell Culture TechniquesMolecular ScaleValidationScreeningMolecular ProfilingPathway AnalysisNetwork ModelsBrain RegionS Disease ModelPathologyBiologyData SetPathogenesisBase
Grant awards (26)
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$2,272,422
U01 · FY2022 · AG
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$1,848,040
U01 · FY2021 · AG
Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease$877,246
R01 · FY2021 · AG · contact PI
Identification and characterization of receptors targeting VGF-derived peptides.$169,500
U01 · FY2021 · AG
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$3,115,604
U01 · FY2020 · AG
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$1,265,373
U01 · FY2020 · AG
Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease$877,246
R01 · FY2020 · AG · contact PI
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$164,076
U01 · FY2020 · AG
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$1,691,295
U01 · FY2019 · AG
Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease$877,246
R01 · FY2019 · AG · contact PI
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$423,750
U01 · FY2019 · AG
Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease$1,708,836
U01 · FY2018 · AG
Use of iPSC systems to define roles of microglial TREM2/DAP12 and CR3/DAP12 complexes and their genetic variants in specifying risk for late onset sporadic Alzheimer's disease$641,748
R01 · FY2018 · AG · contact PI
Towards a comprehensive signaling pathway map of parahippocampal vulnerability in Alzheimers Disease$3,514,658
RF1 · FY2017 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease$2,699,009
U01 · FY2017 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease$169,498
U01 · FY2017 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease$3,281,179
U01 · FY2016 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease$1,139,520
U01 · FY2016 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease$168,108
U01 · FY2016 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease$1,702,824
U01 · FY2015 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease$111,000
U01 · FY2015 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease$96,335
U01 · FY2015 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease$1,734,746
U01 · FY2014 · AG
Accelerating Medicine Partnership in Alzheimer's Disease: Enabling collaborative$114,059
U01 · FY2014 · AG
Integrative Biology Approach to Complexity of Alzheimer's Disease$1,659,748
U01 · FY2013 · AG
Generation and Characterization of Alzheimer Brain Cells$515,809
RF1 · FY2012 · AG